Product name: AHU-377(heMicalciuMsalt)

Alias:AHU-377(heMicalciuMsalt);(alphaR,gammaS)-gamma-[(3-Carboxy-1-oxopropyl)amino]-alpha-methyl-[1,1'-biphenyl]-4-pentanoicacid4-ethylestercalciumsalt(2 :1);(2S,4R)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoicacidethylester,calciumsalt(2:1);AHU-377hemicalciumsalt(2:1) ;Calciumbis(4-{[(1S,3R)-1-([1,1'-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino}-4-oxobutanoate); LCZ696(valsartan+sacubitril)impurity1;Ethyl(αR,γS)-γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-[1,1'-biphenyl]-4-pentanoatehemicalciumsalt;(alphar

CAS No.:1369773-39-6

Molecular formula: C48H56CaN2O10

Molecular weight: 861.04364

Structural formula:

Uses: Mosapride is a blood pressure medication used in combination with Valsartan. The Valsartan/Mosapride combination, dubbed LCZ696 in trials, is a treatment for heart failure. This product is used as the drug intermediate and impurity reference substance for drug application and testing.